Golden Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	44.58	40.92	63.43	217.83	81.77	88.83
Revenue Growth (YoY)	-22.45%	-35.49%	-70.88%	166.39%	-7.95%	6.64%
Cost of Revenue	55.77	47.93	47.37	66.03	69.08	64.17
Gross Profit	-11.19	-7.01	16.06	151.79	12.69	24.66
Selling, General & Admin	199.61	197.47	179.12	170.14	171.43	177.93
Research & Development	94.21	153.22	202.52	278.42	265.1	194.77
Operating Expenses	293.82	350.69	381.64	448.56	436.53	372.59
Operating Income	-305.01	-357.7	-365.58	-296.77	-423.85	-347.94
Interest Expense	-10.54	-8.42	-6.73	-4.08	-3.69	-4.14
Interest & Investment Income	1.54	2.4	8.81	4.33	0.33	0.28
Currency Exchange Gain (Loss)	-1.34	2.75	2.52	26.56	-5.82	-8.13
Other Non Operating Income (Expenses)	0.41	0.24	0.3	0.22	1.51	0.54
EBT Excluding Unusual Items	-314.93	-360.73	-360.68	-269.74	-431.52	-359.4
Gain (Loss) on Sale of Investments	-	-	-	-0.23	-	-9.26
Gain (Loss) on Sale of Assets	0.15	0.15	1.01	0.44	-	-0.48
Asset Writedown	-0.04	-	-1.68	-2.23	-10.01	-19.2
Other Unusual Items	0	0	-	-	-	-0.49
Pretax Income	-314.81	-360.58	-361.35	-271.76	-441.53	-388.82
Income Tax Expense	0.12	0.12	0.29	0.12	2.3	2.55
Net Income	-314.93	-360.7	-361.64	-271.88	-443.84	-391.38
Net Income to Common	-314.93	-360.7	-361.64	-271.88	-443.84	-391.38
Shares Outstanding (Basic)	161	151	142	142	132	126
Shares Outstanding (Diluted)	161	151	142	142	132	126
Shares Change (YoY)	12.93%	5.90%	-	7.36%	5.40%	9.32%
EPS (Basic)	-1.96	-2.39	-2.54	-1.91	-3.35	-3.11
EPS (Diluted)	-1.96	-2.39	-2.54	-1.91	-3.35	-3.11
Free Cash Flow	-238.99	-264.04	-276.2	-260.3	-207.31	-269.02
Free Cash Flow Per Share	-1.49	-1.75	-1.94	-1.83	-1.56	-2.14
Gross Margin	-25.09%	-17.14%	25.31%	69.69%	15.52%	27.76%
Operating Margin	-684.15%	-874.18%	-576.36%	-136.24%	-518.35%	-391.71%
Profit Margin	-706.41%	-881.51%	-570.15%	-124.81%	-542.80%	-440.61%
Free Cash Flow Margin	-536.07%	-645.30%	-435.45%	-119.50%	-253.53%	-302.87%
EBITDA	-280.29	-329.94	-331.43	-258.17	-386.21	-307.82
EBITDA Margin	-	-	-	-118.52%	-	-
D&A For EBITDA	24.72	27.76	34.15	38.6	37.64	40.11
EBIT	-305.01	-357.7	-365.58	-296.77	-423.85	-347.94
EBIT Margin	-	-	-	-136.24%	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.